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Aims
To determine the outcomes following revision surgery of metal-on-metal hip arthroplasties 
(MoMHA) performed for adverse reactions to metal debris (ARMD), and to identify factors 
predictive of re-revision.
Patients and Methods
We performed a retrospective observational study using National Joint Registry (NJR) data 
on 2535 MoMHAs undergoing revision surgery for ARMD between 2008 and 2014. The 
outcomes studied following revision were intra-operative complications, mortality and re-
revision surgery. Predictors of re-revision were identified using competing-risk regression 
modelling.
Results
Intra-operative complications occurred in 40 revisions (1.6%). The cumulative five-year 
patient survival rate was 95.9% (95% confidence intervals (CI) 92.3 to 97.8). Re-revision 
surgery was performed in 192 hips (7.6%). The cumulative five-year implant survival rate was 
89.5% (95% CI 87.3 to 91.3). Predictors of re-revision were high body mass index at revision 
(subhazard ratio (SHR) 1.06 per kg/m2 increase, 95% CI 1.02 to 1.09), modular component 
only revisions (head and liner with or without taper adapter; SHR 2.01, 95% CI 1.19 to 3.38), 
ceramic-on-ceramic revision bearings (SHR 1.86, 95% CI 1.23 to 2.80), and acetabular bone 
grafting (SHR 2.10, 95% CI 1.43 to 3.07). These four factors remained predictive of re-revision 
when the missing data were imputed.
Conclusion
The short-term risk of re-revision following MoMHA revision surgery performed for ARMD 
was comparable with that reported in the NJR following all-cause non-MoMHA revision 
surgery. However, the factors predictive of re-revision included those which could be 
modified by the surgeon, suggesting that rates of failure following ARMD revision may be 
reduced further.
Cite this article: Bone Joint J 2017;99-B:1020–7.
The early observations following revision sur-
gery of metal-on-metal hip arthroplasty
(MoMHA) performed for adverse reactions to
metal debris (ARMD) suggested a high preva-
lence of short-term complications and re-
revisions.1,2 Following revision for ARMD, the
most frequent modes of subsequent failure
have been reported as dislocation, recurrent
ARMD and acetabular loosening.3 In addition,
implant survival and patient-reported out-
comes have been inferior for MoMHAs revised
for ARMD compared with other indications,
and compared with matched patients undergo-
ing primary total hip arthroplasty (THA).1
This is most likely to be related to the poten-
tially destructive nature of ARMD.1,4,5 Fur-
thermore, the ten-year implant rate of survival
following ARMD revision was recently
reported to be only 56%, with surviving
patients continuing to have poor patient-
reported outcomes at extended follow-up.6
Some studies have assessed factors predic-
tive of poor outcomes following revision for
ARMD.5,7,8 However, these studies were small
and therefore underpowered for the identifica-
tion of prognostic factors. There are still many
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MoMHA patients who are likely to require revision surgery
for ARMD in the future.3 Therefore, it is important that
surgeons have information concerning the expected out-
comes in order to appropriately counsel patients regarding
any potential risks. Furthermore, knowledge of prognostic
factors will assist surgeons when making decisions regard-
ing the reconstructive procedure and post-operative surveil-
lance. Large cohort studies are ideally suited to answer
these important clinical questions. The National Joint Reg-
istry (NJR) for England and Wales was established in 2002
(and began collecting data on hip and knee joint replace-
ments in April 2003) to facilitate the early identification of
poorly performing implants.9 It is the largest arthroplasty
registry in the world, and contains the details of two million
joint replacement procedures. 
We used NJR data to assess the outcomes following revi-
sion surgery of MoMHAs performed for ARMD, and to
identify factors predictive of re-revision surgery.
Patients and Methods
A retrospective observational study was performed using
all data submitted to the NJR up to 14 August 2015. This
dataset included details of all primary MoMHAs (THA and
hip resurfacing, HR) which subsequently underwent revi-
sion surgery for adverse soft-tissue reaction to particulate
debris as recorded in the NJR between 01 June 2008 and 14
August 2014 (n = 2567). We have elected to classify this
revision indication as ARMD throughout, given that this is
currently the most commonly used term in the literature.10
This dataset did not include primary MoMHAs revised to
another MoMHA for non-ARMD indications (such as
fracture, loosening, osteonecrosis) before subsequent revi-
sion for ARMD,6 as we did not wish to include patients
who had undergone multiple procedures. ARMD was first
introduced on the NJR data capture forms as an indication
for revision surgery in June 2008. The cut-off date of 14
August 2014 allowed a minimum follow-up period of one
year for outcome assessment. Prior to obtaining the dataset
the entire NJR database was linked with the Office for
National Statistics database, which provides data on all-
cause patient mortality, using unique patient identifiers.
Patients were subsequently excluded from the cohort for
the following reasons: the ARMD revision was recorded in
the NJR as the first stage (excision arthroplasty) of a two-
stage procedure, but the second stage re-implantation pro-
cedure was absent from the NJR (18 hips excluded); the
first stage was recorded as performed for ARMD, but the
second stage was recorded as performed for non-ARMD
indications such as infection (ten hips excluded); it was not
possible to determine whether the primary MoMHA was a
THA or HR from the recorded component information
(four hips excluded). The final cohort for analysis included
2535 primary MoMHAs undergoing revision surgery for
ARMD.
Unique patient identifiers allowed linkage of all ARMD
revisions to the primary MoMHA and any future re-
revisions. For all procedures, the NJR collects data on
patient demographics (age, gender, body mass index (BMI),
American Society of Anesthesiologists grade),11 the surgery
performed (indication, venous thromboembolism prophy-
laxis, surgeon grade, approach, components implanted
including bearing surface, size, and fixation), and the
occurrence of intra-operative complications (calcar crack,
pelvic and/or femoral shaft penetration, trochanteric and/
or femoral shaft fracture, and other complications). In
addition, intra-operative findings are recorded for revision
procedures. Patient and surgical factors relating to the
ARMD revision procedure were used as covariates when
assessing predictors of re-revision surgery. Outcomes of
interest were intra-operative complications during ARMD
revision, and all-cause mortality and all-cause re-revision
surgery following ARMD revision.
Statistical analysis. All analyses were performed using
Stata Version 14.2 (StataCorp LLC, College Station,
Texas). The significance level for all analyses was a p-value
< 0.05, with 95% confidence intervals (CI) also used. Diff-
erences in patient and surgical factors between re-revised
and non-re-revised hips were assessed using either unpaired
t-tests or the Wilcoxon rank-sum test (numerical data), and
either the chi-squared test or Fisher’s exact test (categorical
data). Cumulative patient and implant survival rates fol-
lowing ARMD revision surgery were determined using the
Kaplan-Meier method. The endpoint for implant survival
was re-revision surgery (removal or exchange of any com-
ponent). Patients not undergoing re-revision who remained
alive were censored on the study end date (14 August
2015).
Fine and Gray12 competing-risk regression modelling
was used to identify predictors of re-revision surgery as
mortality can be considered a competing risk. Univariable
models explored the association between each predictor
and re-revision surgery. Linearity of continuous predictors
with outcome (re-revision) was assessed using fractional
polynomials, with data grouped if effects were non-linear.
The proportional subhazards assumption was satisfied for
all predictors. The final multivariable competing-risk
regression model was developed using stepwise selection
methods. The p-values for the removal and inclusion of pre-
dictors in the final multivariable model were p ≥ 0.20 and
p < 0.10, respectively. The discriminatory ability of the
final multivariable model for distinguishing between hips
that did or did not undergo re-revision surgery was ana-
lysed using the concordance (c) statistic. The c statistic
(range 0 to 1; useful prognostic models = 0.60 to 0.85) pro-
vides a global assessment of fit for the survival model, and
is equivalent to the area under a receiver operating charac-
teristic curve.13,14 
There were four covariates with missing data (BMI
n = 682; revision procedure n = 5; revision femoral head
size n = 29; revision bearing surface n = 119). As a sensi-
tivity analysis, regression models were repeated using a
complete dataset where missing data were imputed.
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Multiple imputation is an accepted statistical method for
managing missing data.15 In total, 50 complete datasets
were imputed, with data assumed to be missing at ran-
dom. Imputation models included all other covariates
from the regression analyses with complete data available
and the study outcome (Nelson-Aalen estimate, and
whether the hip was re-revised), given that all of these fac-
tors carried information about the missing values.
Results
Intra-operative complications. Of the 2535 MoMHAs revised
for ARMD (Table I), intra-operative complications
Table I. Patient and surgical factors for all metal-on-metal hip arthroplasties revised for adverse reactions to metal debris (ARMD) with hips not
undergoing re-revision surgery compared with those undergoing re-revision surgery
Covariate All ARMD hip revisions (n = 2535) (100%)
ARMD hip revisions not undergoing re-revision 
surgery (n = 2343) (92.4%)
ARMD hip revisions undergoing re-revision 
surgery (n = 192) (7.6%) p-value
Gender, n (%)
Female 1509 (59.5) 1388 (59.2) 121 (63.0) 0.305
Age at revision (yrs)
Mean (SD) 63.6 (10.1) 63.7 (10.0) 62.3 (11.0) 0.1045
BMI (kg/m2)*
Mean (SD) 29.0 (5.1) 28.9 (5.1) 30.1 (5.7) 0.0179
Bilateral revisions for ARMD, n (%) 224 (8.8) 206 (8.8) 18 (9.4) 0.784
Primary arthroplasty, n (%)
THA 1716 (67.7) 1572 (67.1) 144 (75.0) 0.024
HR 819 (32.3) 771 (32.9) 48 (25.0)
Primary femoral head size (mm), n (%)
≤ 36 470 (18.5) 429 (18.3) 41 (21.4) 0.737
38 to 44 751 (29.6) 696 (29.7) 55 (28.7)
46 to 50 1102 (43.5) 1020 (43.5) 82 (42.7)
≥ 52 212 (8.4) 198 (8.5) 14 (7.3)
Time from primary to revision (yrs)
Mean (SD) 5.2 (1.8) 5.3 (1.8) 4.7 (1.9) < 0.0001
ASA grade at revision, n (%)
1 476 (18.8) 438 (18.7) 38 (19.8) 0.769
2 1827 (72.1) 1688 (72.0) 139 (72.4)
3 or above 232 (9.2) 217 (9.3) 15 (7.8)
VTE – chemical, n (%)
LMWH (+/-other) 1309 (51.6) 1219 (52.0) 90 (46.9) 0.167
Aspirin only 68 (2.7) 62 (2.7) 6 (3.1)
Other 922 (36.4) 852 (36.4) 70 (36.5)
None 236 (9.3) 210 (9.0) 26 (13.5)
VTE – mechanical, n (%)
Any vs none 2447 (96.5) 2263 (96.6) 184 (95.8) 0.584
Number of ARMD hip revision procedures performed by each of 237 centres 
Median (range) 28 (1 to 169) 28 (1 to 169) 34 (1 to 169) 0.0532
Revision surgeon grade, n (%)
Consultant vs other 2430 (95.9) 2247 (95.9) 181 (95.3) 0.693
Surgical approach
Posterior vs other 2084 (82.2) 1929 (82.3) 155 (80.7) 0.577
Revision indications/intra-operative findings, n (%)
ARMD only 1604 (63.3) 1474 (62.9) 130 (67.7) 0.185
2 to 6 indications 931 (36.7) 869 (37.1) 62 (32.3)
ARMD 2535 (100) 2343 (100) 192 (100) NA
Pain 554 (21.9) 522 (22.3) 32 (16.7) 0.070
Aseptic loosening (any) 219 (8.6) 206 (8.8) 13 (6.8) 0.338
Acetabular loosening 125 (4.9) 118 (5.0) 7 (3.7) 0.392
Femoral loosening 112 (4.4) 105 (4.5) 7 (3.7) 0.588
Osteolysis (any) 177 (6.9) 166 (7.1) 11 (5.7) 0.479
Acetabular osteolysis 110 (4.3) 104 (4.4) 6 (3.1) 0.390
Femoral osteolysis 101 (4.0) 95 (4.1) 6 (3.1) 0.527
Other abnormal findings 85 (3.4) 81 (3.5) ‡ 0.405
Implant malalignment 79 (3.1) 76 (3.2) ‡ 0.278
Acetabular component wear 43 (1.7) 40 (1.7) ‡ 1.00
Fracture 43 (1.7) 39 (1.7) ‡ 0.563
Dislocation/subluxation 37 (1.5) 29 (1.2) 8 (4.2) 0.005
Infection 22 (0.9) 19 (0.8) ‡ 0.230
Incorrect implant size 9 (0.4) 8 (0.3) ‡ 0.508
Liner dissociation 9 (0.4) 9 (0.4) 0 (0) 1.00
Implant fracture 6 (0.2) 6 (0.3) 0 (0) 1.00
Revision procedure,* n (%)
All components revised 1032 (40.8) 968 (41.4) 64 (33.5) 0.031
Acetabular component (+/- head +/- liner +/- taper adapter) 1163 (46.0) 1071 (45.8) 92 (48.2)
Femoral component (+/- head +/- liner +/- taper adapter) 78 (3.1) 73 (3.1) ‡
Modular components only† 257 (10.2) 227 (9.7) 30 (15.7)
Revision femoral head size (mm),* n (%)
Mean (SD) 34.3 (3.2) 34.2 (3.2) 34.4 (3.4) 0.418
Range 22.25 to 48 22.25 to 44 22.25 to 48
< 36 882 (35.3) 820 (35.5) 62 (33.0) 0.751
36 1486 (59.5) 1371 (59.4) 115 (61.2)
> 36 130 (5.2) 119 (5.2) 11 (5.9)
Revision bearing surface,* n (%)
CoP 1104 (45.7) 1040 (46.5) 64 (35.4) 0.017
CoC 765 (31.7) 693 (31.0) 72 (39.8)
MoP 533 (22.1) 488 (21.8) 45 (24.9)
CoM, MoM or MoC 14 (0.6) 14 (0.6) 0 (0)
Acetabular component fixation, n (%)
Cementless 1919 (87.5) 1780 (87.3) 139 (89.1) 0.522
Cemented 275 (12.5) 258 (12.7) 17 (10.9)
Femoral component fixation, n (%)
Cementless 723 (65.3) 674 (64.9) 49 (71.0) 0.299
Cemented 385 (34.8) 365 (35.1) 20 (29.0)
Bone graft (femoral), n (%) 76 (3.0) 71 (3.0) ‡ 0.739
Bone graft (acetabular), n (%) 509 (20.1) 457 (19.5) 52 (27.1) 0.012
*missing data for stated number of hips: BMI (n = 682); revision procedure (n = 5); revision femoral head size (n = 29); revision bearing surface (n = 119)
†involves revision of the femoral head and liner, with or without the use of a taper adapter 
‡data suppressed due to small count within the cell. The actual number was between 1 and 5
Statistically significant differences between the re-revised and non-re-revised hips (p < 0.05) are highlighted in bold text 
All numerical data were compared using unpaired t-tests, apart from the number of ARMD hip revision procedures performed by each centre, which was compared using the Wilcoxon rank-sum test. All categorical data 
were compared using the chi-squared test, apart from the following covariates, which were compared using Fisher’s exact test: certain revision indications (other abnormal findings; implant malalignment; acetabular com-
ponent wear; fracture; infection; incorrect implant size; liner dissociation; implant fracture), revision procedure, revision bearing surface, and bone graft (femoral)
SD, standard deviation; BMI, body mass index; THA, total hip arthroplasty; HR, hip resurfacing; ASA, American Society of Anesthesiologists; VTE, venous thromboembolism; LMWH, low molecular weight heparin; CoP, 
ceramic-on-polyethylene; CoC, ceramic-on-ceramic; MoP, metal-on-polyethylene; CoM, ceramic-on-metal; MoM, metal-on-metal; MoC, metal-on-ceramic; NA, not applicable
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occurred in 40 hips (1.6%). The most common complica-
tions were fractures of the calcar (n = 11, 27.5%) and
greater trochanter (n = 8, 20.0%).
Patient mortality. Overall mortality following revision sur-
gery was 1.6% (n = 41). The mean time from ARMD revi-
sion to death was 1.9 years (0.1 to 5.9); no patient who died
during the follow-up period had undergone re-revision.
The cumulative one-year and five-year patient survival rate
following ARMD revision was 99.4% (95% CI 99.1 to
99.7) and 95.9% (95% CI 92.3 to 97.8) respectively.
Re-revision surgery. Following ARMD revision, re-revision
was performed in 192 hips (7.6%) at a mean of 1.2 years
(one day to 5.7 years). In re-revised hips, 71 (37.0%) had
more than one indication for failure. The most common re-
revision indications were pain (n = 52, 27.1%), ARMD (n =
48, 25.0%), dislocation or subluxation (n = 43, 22.4%),
infection (n = 31, 16.1%) and acetabular loosening (n = 29,
15.1%) (Table II). 
The mean follow-up time for hips not undergoing re-
revision was 2.9 years (1.0 to 6.6). The cumulative five-year
implant survival rate following ARMD revision was 89.5%
(95% CI 87.3 to 91.3) (Fig. 1).
Predictors of re-revision surgery: univariable analysis. Uni-
variable analysis identified six predictors of re-revision
(Table III): high BMI at revision; primary THA (compared
with HR); shorter interval between primary and revision
surgery; modular component only revisions (femoral head
and liner with or without taper adapter); ceramic-on-
ceramic revision bearings and acetabular bone grafting.
Predictors of re-revision surgery: multivariable analysis. The
final multivariable model included 1766 hips (70% of the
cohort) with data available for all variables, including BMI.
Four predictors from the univariable analysis remained sig-
nificant predictors of re-revision in the multivariable model
(Table III): high BMI at revision (subhazard ratio (SHR)
1.06 per kg/m2 increase; 95% CI 1.02 to 1.09; p = 0.001);
modular component only revisions (SHR 2.01; 95%
CI 1.19 to 3.38; p = 0.009); ceramic-on-ceramic revision
bearings (SHR 1.86; 95% CI 1.23 to 2.80; p = 0.003);
acetabular bone grafting (SHR 2.10; 95% CI 1.43 to 3.07;
p < 0.001). Type of primary joint arthroplasty (THA
versus HR) was not eligible for final model inclusion
(p = 0.670). Time between primary and revision surgery
was included in the final model, but did not reach statisti-
cal significance (p = 0.067). The final multivariable model
had a reasonable discriminatory ability for distinguishing
between hips undergoing and not undergoing re-revision
Table II. Indications for metal-on-metal hip arthroplasties undergoing re-revision surgery following revision surgery
performed for adverse reactions to metal debris (n = 192)
Re-revision indications and intra-operative findings Events, n (%)
Overall 291 causes in 192 re-revised hips
Hips with one indication 121 (63.0)
Hips with two to four indications 71 (37.0)
Specific indications
Pain 52 (27.1)
Adverse reactions to metal debris 48 (25.0)
Dislocation/subluxation 43 (22.4)
Deep infection 31 (16.1)
Aseptic loosening – acetabular 29 (15.1)
Aseptic loosening – femoral 15 (7.8)
Implant malalignment – acetabular 15 (7.8)
Osteolysis – femoral 10 (5.2)
Other indication 10 (5.2)
Periprosthetic fracture – femoral 8 (4.2)
Periprosthetic fracture – acetabular 8 (4.2)
Acetabular component wear 8 (4.2)
Other (including femoral malalignment, implant fracture, and liner dissociation) 8 (4.2)
Osteolysis – acetabular 6 (3.1)
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Fig. 1
Kaplan-Meier cumulative implant survival rate following revision sur-
gery performed for adverse reactions to metal debris at up to five
years. The shaded area represents the respective upper and lower lim-
its of the 95% confidence intervals (CIs). Risk table indicates the num-
ber of hips at risk at one-year intervals, with the corresponding
number in brackets detailing the number of hips undergoing re-
revision surgery during each one-year interval. The one re-revision
which was performed more than five years following revision surgery
is not included in the risk table. The cumulative five-year implant rate
of survival was 89.5% (95% CI 87.3 to 91.3).
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surgery (c statistic = 0.66). When using the imputed data-
set, high BMI at revision, modular component only revi-
sions, ceramic-on-ceramic revision bearings and
acetabular bone grafting were also identified as significant
predictors of re-revision (supplementary table available
online).
Modular component only revisions had an increased risk
of re-revision compared with hips undergoing all compo-
nent revisions (SHR 2.03; 95% CI 1.17 to 3.54; p = 0.012),
and compared with hips undergoing acetabular component
revisions (with or without head, liner, taper adapter revi-
sion) (SHR 2.01; 95% CI 1.19 to 3.38; p = 0.009). Re-
revisions following modular component only revisions
(n = 30) were most frequently for dislocation or subluxa-
tion (n = 10, 33.3%) and infection (n = 8, 26.7%).
Ceramic-on-ceramic revision bearings had an increased risk
of re-revision compared with hips revised with ceramic-on-
polyethylene bearings (SHR 1.86; 95% CI 1.23 to 2.80;
p = 0.003), but not compared with hips revised with metal-
on-polyethylene bearings (SHR 1.27; 95% CI 0.80 to 2.02;
p = 0.308). Re-revisions following the use of ceramic-on-
ceramic revision bearings (n = 74) were most frequently for
pain (n = 25, 33.8%), ARMD (n = 20, 27.0%) and acetab-
ular loosening (n = 16, 21.6%). 
Discussion
We observed few intra-operative complications during revi-
sion surgery for ARMD (1.6%). Similar to previous studies,
fractures of the femur represented the most common com-
plication.16 Mortality rates following ARMD revision were
Table III. Univariable and multivariable Fine and Gray12 competing-risk (mortality) regression analysis to identify predictors of re-revision surgery
following revision surgery performed for adverse reactions to metal debris (ARMD)
Covariate Univariable subhazard ratio (95% CI) p-value Multivariable subhazard ratio (95% CI) p-value
Gender
Female vs male 1.14 (0.85 to 1.55) 0.382 †
Age at revision (per yr) 0.99 (0.98 to 1.01) 0.455 †
BMI (per kg/m2) 1.05 (1.02 to 1.08) 0.003 1.06 (1.02 to 1.09) 0.001
Bilateral revisions for ARMD 1.03 (0.63 to 1.70) 0.901 †
Primary hip arthroplasty
HR 1.00 Ref †
THA 1.47 (1.05 to 2.06) 0.023
Time from primary to revision (per yr) 0.87 (0.79 to 0.95) 0.002 0.91 (0.81 to 1.01) 0.067
ASA grade at revision
1 1.00 Ref 1.00 Ref
2 1.00 (0.69 to 1.45) 0.989 * 0.946
3 or above 0.92 (0.50 to 1.70) 0.798 0.58 (0.28 to 1.21) 0.147
VTE – chemical
None 1.00 Ref †
LMWH (+/-other) 0.66 (0.42 to 1.04) 0.074
Aspirin only 0.87 (0.35 to 2.12) 0.753
Other 0.72 (0.45 to 1.15) 0.173
VTE – mechanical
Any vs none 0.79 (0.39 to 1.60) 0.509 †
Number of ARMD hip revision procedures performed by each centre 
(per 10 cases) 
1.02 (0.99 to 1.05) 0.118 1.03 (0.99 to 1.06) 0.056
Revision surgeon grade
Consultant vs other 0.83 (0.42 to 1.62) 0.583 †
Surgical approach
Posterior vs other 0.91 (0.63 to 1.32) 0.624 †
Revision indications
ARMD only
2 to 6 indications
1.00
0.80 (0.58 to 1.09)
Ref 
0.156
†
Revision details
Acetabular component (+/- head +/- liner +/- taper adapter) 1.00 Ref 1.00 Ref
All components revised 0.78 (0.56 to 1.07) 0.126 * 0.878
Femoral component (+/- head +/- liner +/- taper adapter) 0.22 (0.30 to 1.59) 0.133 ‡ ‡
Modular components only§ 1.59 (1.04 to 2.43) 0.032 2.01 (1.19 to 3.38) 0.009
Revision femoral head size
< 36 mm 1.00 Ref †
36 mm 1.12 (0.82 to 1.53) 0.491
> 36 mm 1.04 (0.53 to 2.02) 0.915
Revision bearing surface
CoP 1.00 Ref 1.00 Ref
CoC 1.54 (1.10 to 2.16) 0.013 1.86 (1.23 to 2.80) 0.003
MoP 1.44 (0.98 to 2.10) 0.062 1.45 (0.88 to 2.39) 0.141
CoM, MoM or MoC ‡ ‡ ‡ ‡
Acetabular component fixation
Cementless 1.00 Ref †
Cemented 0.89 (0.54 to 1.47) 0.656
Femoral component fixation
Cementless 1.00 Ref †
Cemented 0.76 (0.44 to 1.30) 0.316
Bone graft (femoral) 0.74 (0.28 to 1.96) 0.541 †
Bone graft (acetabular) 1.52 (1.10 to 2.11) 0.011 2.10 (1.43 to 3.07) < 0.001
*specific subgroup did not meet inclusion criteria for final multivariable model (p > 0.200)
†covariate was not eligible for inclusion in the final multivariable model 
‡unable to calculate value as no hips in this subgroup underwent re-revision surgery
§involves revision of the femoral head and liner, with or without the use of a taper adapter 
All univariable analyses were based on a cohort of 2416 hips with complete data available for all variables, excluding BMI (181 hips undergoing re-revision surgery and 39 deaths) 
Multivariable analysis, and the univariable analysis for BMI were based on a cohort of 1766 hips with data available for all variables, including BMI (132 hips undergoing re-revision surgery and 28 deaths) 
Statistically significant differences between the re-revised and non re-revised hips (p < 0.05) are highlighted in bold text
CI, confidence interval; BMI, body mass index; THA, total hip arthroplasty; HR, hip resurfacing; ASA, American Society of Anesthesiologists; VTE, venous thrombo-embolism; LMWH, low molecular weight heparin; CoP, ceramic-on-
polyethylene; CoC, ceramic-on-ceramic; MoP, metal-on-polyethylene; CoM, ceramic-on-metal; MoM, metal-on-metal; MoC, metal-on-ceramic; Ref, reference group
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also low (4.1% at five years), which is lower than for
primary THA according to NJR data (9.5% at five years).9
However, this is likely to be related to the younger age of
MoMHA patients undergoing revision surgery compared
with the full population of primary THA patients (mean
age 63.6 years versus 69 years, respectively).9
Early studies reported catastrophic short-term outcomes
following ARMD revision, with one-third of patients requir-
ing re-operations.1,2,17 Recent studies have observed better
outcomes with increased surgical experience,8 with a
reported five-year implant rate of survival of 87.9% follow-
ing ARMD revision.7 Although the five-year implant rate of
survival was similar in our study (89.5%) to recent studies,7,8
these outcomes appear inferior compared with the implant
survival following revision of conventional THA performed
at specialist centres.18,19 However, registries may under
report arthroplasty failures,20,21 which makes comparison
with single-centre cohorts problematic. Perhaps the fairest
comparison of our results would be with registry outcomes
following non-MoMHA revision. Although the lack of a
comparator group undergoing non-MoMHA revision sur-
gery is a significant limitation of our study, the NJR does
report implant survival following such procedures.9 The five-
year implant survival rates following all-cause non-MoMHA
revision surgery (with linked primary procedures) recorded
in the NJR are 87.8% to 89.1% for primary metal-on-
polyethylene THAs (depending on the method of fixation),
and 88.2% for primary uncemented ceramic-on-ceramic
THAs.9 Therefore implant survival rates following MoMHA
revision for ARMD appear similar to those in non-MoMHA
patients revised for all indications. However it was not pos-
sible to adjust for potential confounding factors, given the
non-MoMHA revision outcome data were obtained from
the latest NJR report.9 Furthermore, as most patients who
underwent MoMHA were young and active,22 consideration
should be given to patient-reported outcome measures fol-
lowing revision but these were not available. Registries do
not collect data on patient-reported outcomes following revi-
sion, or on non-revision procedures.9
Re-revisions following ARMD surgery occurred early,
with the indications for re-revision similar to previous
reports.3 Dislocation can occur as the soft-tissue destruc-
tion of ARMD may require extensive debridement, and the
diameter of the femoral head is commonly reduced.2,8 The
risk of infection is increased by repeat surgery and incom-
plete excision of metal debris and necrotic tissue, whilst
ARMD-induced osteolysis may lead to loosening of the ace-
tabular component.2,3 Recurrence of ARMD has been
reported following revision,3 and in this series ARMD was
recorded in 25% of all re-revision cases. This is concerning
given the short-term follow-up and exchange to non-MoM
bearings in all hips. 
The final multivariable model was only reasonable for
distinguishing between those hips which either did or did
not undergo re-revision surgery. Registry based models are
unlikely to have much better discriminatory ability given
they do not collect data on variables such as blood metal
ion levels and the findings from imaging. However, our
final model did provide four predictors of re-revision with
large effect sizes. 
High BMI at revision and acetabular bone grafting were
both associated with an increased risk of future re-revision.
We consider these to be largely non-modifiable risk factors.
High BMI also predicts re-revision following revision THA
performed for non-ARMD indications.23,24 Patients who
required acetabular bone grafting had twice the risk of re-
revision. Bone grafting suggests a more complex recon-
struction, which may be required because of ARMD-
induced osteolysis and/or iatrogenic bone loss from the
removal of well-fixed components.5,7,8 Alternatively ace-
tabular bone grafting may represent a modifiable risk fac-
tor if the reasons for the higher re-revision rates are related
to this strategy being ineffective for managing ARMD-
induced osteolysis compared with other reconstructive
methods. Complications associated with bone grafts
include infection, component migration and loosening,
which can all require further surgery.25 
Modular component only revisions and ceramic-on-
ceramic revision bearings both predicted future re-
revision, and represent modifiable surgical risk factors.
Some surgeons advise retaining well-fixed and well-
positioned components at revision for ARMD, with
exchange of the modular components to non-MoM bear-
ings.2,26 Taper adapters are also recommended if tapers
are not severely damaged.2,27 Modular exchange is attrac-
tive, to prevent the morbidity associated with the removal
of well-fixed components.16,28 However, there is little evi-
dence to support this approach.2,27 We observed that
modular component-only revisions had twice the risk of
re-revision compared with all component revisions and
acetabular component-only revisions. Failures following
modular revision were commonly due to dislocation. This
supports the evidence from previous studies employing
this strategy,2,27 suggesting hip stability is difficult to con-
trol after ARMD revision with modular component
exchange alone. As component malposition represents an
important risk factor for subsequent revision of
THAs,29,30 the failure to correct any component malposi-
tion would be expected to increase the risk of future revi-
sion. However, the NJR does not collect information on
component positioning. It is hoped that future studies
with detailed radiographic data available could investi-
gate this further.
There is no consensus on which non-MoM bearing sur-
face should be used when revising for ARMD. Ceramic
bearings are popular because MoMHA revision patients
are generally young and active.2,5,6,8 However, we observed
that ceramic-on-ceramic bearings have an 86% increased
risk of re-revision compared with ceramic-on-polyethylene
bearings. It is unclear why hard-on-hard ceramic bearings
have inferior outcomes, with re-revision indications in this
subgroup being consistent with the whole cohort. However,
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our analysis is limited as we do not know the specific type
of ceramic head implanted. Our findings that ceramic-on-
polyethylene bearings have the lowest re-revision risk fol-
lowing ARMD revision complement the registry observa-
tions of a lower failure rate for this bearing surface in
primary THA.9,31 
Primary MoM THA has an inferior survivorship com-
pared with HR, even when bearing surfaces from the same
manufacturer are implanted.9,32,33 We observed that in
MoMHAs undergoing ARMD revision, the primary implant
(THA versus HR) did not influence the future re-revision
risk. Although limited evidence is available, previous studies
have also not identified any difference in outcome following
ARMD revision between THAs and HRs.3,7
The strengths of our study include the use of linked data
from the largest arthroplasty registry in the world, which
provides details of the primary MoMHA and all subse-
quent procedures. Furthermore, the assessment of an unse-
lected population will reduce the likelihood of sampling
bias. Therefore, we suspect our findings have good external
validity and generalisability. Given the large number of re-
revisions, our regression models were not over-fitted.
Nevertheless, registries have numerous potential limitations,
which could affect our findings. The use of observational data
means we cannot infer causality. Non-registry validation is
therefore recommended. However, it would be difficult to
achieve this with adequate statistical power as specialist centres
perform relatively few ARMD revisions.1-3,5,7,8,26 Another
important limitation is that no large scale validation of the
NJR has been performed. Recent studies to validate
MoMHA retrievals using NJR data concluded that
although revision rates may be underestimated, the com-
pleteness of data and accuracy of procedures which were
recorded within the NJR were excellent.20,21 Therefore we
assume our study only involves a sample of all ARMD revi-
sions actually performed, and the subsequent rate of failure
may also be underestimated. However, details of the cases
included are likely to be accurate. 
A further limitation is that MoMHA revision rates vary
both regionally and between surgeons.9,31,34,35 Various cen-
tres and surgeons may have used different criteria for both
diagnosing ARMD and performing revisions. The ARMD
revisions analysed here are suspected to comprise a hetero-
geneous group, ranging from small collections around the
arthroplasty and/or metallosis to large invasive and
destructive lesions.1,5,7,8 Furthermore, as the NJR does not
collect histopathological data, it is possible that some
MoMHAs truly revised for ARMD have been missed as
they may have been recorded with different indications in
the NJR. Conversely some ARMD revisions in this study
may have been misdiagnosed intra-operatively and were
revised for non-ARMD indications, such as infection. 
Although our findings have been compared with data on
all primary hips from the NJR report,9 the lack of raw data
means that we cannot determine how the predictors
identified here (such as high BMI and acetabular bone
grafting) influence outcomes following non-MoMHA revi-
sions. Although missing data for some variables (namely
BMI) could potentially affect the final model, our findings
were confirmed when missing data were imputed (supple-
mentary table available online). Further surgery represents
an important outcome measure, but some procedures will
not have been captured by the NJR, such as closed reduc-
tions of dislocations, debridement and washouts for infec-
tion and internal fixation for periprosthetic fractures.
Finally, although we assessed the effect of primary MoM
implant (THA versus HR) on re-revision rates, it was not
possible to stratify the analysis further by implant manufac-
turer as we were not allowed access to this sensitive data by
the registry and manufacturers. 
Data from the largest arthroplasty registry in the world
have demonstrated that the short-term risk of re-revision fol-
lowing MoMHA revision surgery performed for ARMD was
comparable with that reported within the NJR following all-
cause non-MoMHA revision.9 However predictors of re-
revision included factors that the surgeon can modify intra-
operatively (type of revision procedure and bearing surface).
Surgeons may therefore be able to reduce the rate of failure
further following ARMD revision. Our findings may be useful
when advising MoMHA patients about the risks associated
with revision surgery for ARMD, and for making decisions
regarding the type of hip reconstruction to perform.
Take home message:
- Factors predictive of re-revision following ARMD revision
surgery included modifiable factors (type of revision proce-
dure and bearing surface), which suggests that surgeons may reduce fail-
ure rates further following ARMD revision.
Supplementary material
A table showing the competing risk regression analy-
sis in a complete dataset, where missing data were
imputed, is available alongside the online version of this
article at www.bjj.boneandjoint.org.uk
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